Le Lézard
Classified in: Health
Subject: SVY

The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018


NEW YORK, Jan. 21, 2020 /PRNewswire/ --

The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2019-2027.

Read the full report: https://www.reportlinker.com/p05774503/?utm_source=PRN

The market is driven by the factors such as, rising incidence of diabetes, growing geriatric population, increasing prevalence of obesity across the globe, and rapid technological advancement in diabetes care devices. However, the factors restraining the market growth are high cost of diabetes care devices and risks associated with the insulin delivery devices.
Obesity, sedentary lifestyle and improper diet play a major role in increasing diabetes among the population worldwide.Physical activity is important to maintain the blood glucose level.

Lack of exercise and unhealthy diet such as diet high in fat and calories increase the risk for the development of obesity and diabetes.Obesity is one of the major problem and the biggest concern in all the communities across the globe.

Currently, more than one in two adults and nearly one in six children are obese.Obesity is one of the major issue affect people of all ages and incomes globally.

According to World Health Organization (WHO), in 2016, more than 1.9 billion adults aged 18 years and older were overweight. And out of these over 650 million adults were obese. Therefore, owing to these factors the market is likely to witness growth during the forecast period.
Global diabetes care devices market was segmented by product and end user.The product segment was further divided as glucose monitoring devices and insulin delivery devices.

The glucose monitoring devices is further segmented into Glucometers, Lancets, Testing Strips and Other Glucose Monitoring Devices.The insulin delivery devices is further segmented into insulin pens, insulin syringes, insulin pumps and other insulin delivery devices.

The glucose monitoring devices is expected to dominate its market share in 2027 owing to the rise in the prevalence of the diabetes.Based on the end user the diabetes care device market is segmented into hospitals and clinics and home care.

The homecare held the major market share among the end user segment owing to ease of use, availability, and accessibility of insulin delivery devices.
Some of the major primary and secondary sources included in the report for the diabetes care devices market are World Health Organization, American Diabetes Association, National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes UK, Centers for Disease Control and Prevention, Chinese Diabetes Society, International Diabetes Federation and others.

Read the full report: https://www.reportlinker.com/p05774503/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...



News published on and distributed by: